 | Up a level |
Hu, Bei; Lin, Xiao; Lee, Hans C; Huang, Xuelin; Tidwell, Rebecca S Slack; Ahn, Kwang Woo; Hu, Zhen-Huan; Jabbour, Elias; Verstovsek, Srdan; Ravandi, Farhad; Garcia-Manero, Guillermo; Kharfan-Dabaja, Mohamed A; Hossain, Nasheed M; Marks, David I; Kamble, Rammuriti T; Inamoto, Yoshihiro; Kindwall-Keller, Tamila; Saad, Ayman; Litzow, Mark R; Savani, Bipin N; ... (2020). Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Leukemia & lymphoma, 61(12), pp. 2811-2820. Taylor & Francis 10.1080/10428194.2020.1783444
Schmidt, Sarah; Liu, Ying; Hu, Zhen-Huan; Williams, Kirsten M; Lazarus, Hillard M; Vij, Ravi; Kharfan-Dabaja, Mohamed A; Ortí, Guillermo; Wiernik, Peter H; Weisdorf, Daniel; Kamble, Rammurti T; Herzig, Roger; Wirk, Baldeep; Cerny, Jan; Bacher, Ulrike; Chaudhri, Naeem A; Nathan, Sunita; Farhadfar, Nosha; Aljurf, Mahmoud; Gergis, Usama; ... (2020). The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biology of blood and marrow transplantation, 26(6), pp. 1137-1143. Elsevier 10.1016/j.bbmt.2020.02.006
DeFilipp, Zachariah; Ancheta, Richard; Liu, Ying; Hu, Zhen-Huan; Gale, Robert Peter; Snyder, David; Schouten, Harry C; Kalaycio, Matt; Hildebrandt, Gerhard C; Ustun, Celalettin; Daly, Andrew; Ganguly, Siddhartha; Inamoto, Yoshihiro; Litzow, Mark; Szer, Jeffrey; Savoie, Mary Lynn; Hossain, Nasheed; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Reshef, Ran; ... (2020). Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study. Biology of blood and marrow transplantation, 26(3), pp. 472-479. Elsevier 10.1016/j.bbmt.2019.10.017
